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The Jawaharlal Nehru Medical College (JNMC) Women’s and Children’s Health Research Unit (WCHRU) of the
Karnataka Lingayat Education (KLE) Academy of Higher Education and Research Deemed-to-be-University and its
collaborators convened the ‘2nd International Conference on Maternal and Newborn Health -Translating Research
Evidence to Practice’ to address the common theme of improving maternal and newborn health in low- and
middle- income countries (LMIC). This supplement, including 16 manuscripts, reflects much of the research
presented at the conference, including analyses of the state of knowledge, as well as completed, ongoing and
planned research in these areas conducted by the WCHRU in India together with many collaborators across high-
income and LMIC. The first paper reviews maternal, fetal and neonatal mortality in low-income countries, considers
their causes, as well as evidence for potential interventions to reduce mortality. A second paper addresses near miss
maternal mortality. Several manuscripts address the research conducted by WCHRU and their colleagues in a multi-
center research network. One study examines rates of miscarriage and medically terminated pregnancy in India and
the risk factors for these occurrences. Another paper addresses stillbirth and its risk factors, both in India as well as
in other LMIC. Haemorrhage and preeclampsia/eclampsia, important causes of maternal mortality, stillbirth and
neonatal morbidity in LMIC, are addressed in a series of papers summarizing trials of interventions to reduce
improve outcomes associated with these conditions. Poor maternal and infant nutritional status, which contribute
to adverse outcomes, are addressed through papers which describe a number of important studies that the
WCHRU and their colleagues have conducted to attempt to improve nutritional status. Another paper describes a
study to investigate causes of stillbirth and deaths among preterm births, which will utilize new techniques to
investigate the infectious causes of these deaths. Finally, the supplement addresses the process for dissemination of
research results to inform public policy. Together these manuscripts represent a body of research to inform
interventions to reduce maternal, fetal and newborn mortality and illustrates what a dedicated research group
together with institutional support can accomplish.
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This Reproductive Health Supplement derives from pre-
sentations at a conference celebrating the work of the
Jawaharlal Nehru Medical College (JNMC) Women’s
and Children’s Health Research Unit (WCHRU) of the
Karnataka Lingayat Education (KLE) Academy of Higher
Education and Research Deemed-to-be-University and
its collaborators. This ‘2nd International Conference on
Maternal and Newborn Health-Translating Research
Evidence to Practice’ focuses on the efforts of the
WCHRU as they move toward their goal of becoming
leaders in research and advocacy related to improving
maternal and child health, not only in India but in low-
and middle-income countries worldwide. The primary
focus of the conference is to engage various stakeholders
to share completed and ongoing research and to develop
a roadmap for programmatic implementation. The 16
papers in the supplement represent only a small sample
of this group’s research in recent years.
The Women’s and Children’s Health Research Unit of
Jawaharlal Nehru Medical College of the KLE Academy of
Higher Education and Research
The KLE Academy of Higher Education and Research
Deemed-to-be-University is sponsored by the KLE Society,
a charitable organization with about 13,000 members,
founded in 1916. Its growth has been exponential, from a
single institution in 1916 to 258 institutions in 2017, which
embrace almost all disciplines of education and healthcare.
Today KLE Society has over 16,000 employees and 125,000
students. One of KLE’s institutions is the Jawaharlal Nehru
Medical College where the WCHRU is situated.
It is not only interesting, but also important, to under-
stand why the WCHRU has achieved the success it has.
Most important is the vision held more than 20 years
ago by the group’s founders, Drs. Bhalchandra S. Kod-
kany and Shivaprasad S. Goudar. To support their vi-
sion, they had generous support of the KLE leadership,
especially Chancellor Dr. Prabhakar Kore, a three-time
Member of Parliament in India. In the late 1990’s, the
KLE Society invested a substantial amount of financial
resources for faculty development in the areas of med-
ical education and perinatology through academic col-
laboration with University of Illinois at Chicago. The
Global Network (GN) grant to KLE from the US Na-
tional Institute of Health, as described later, was a direct
result of that collaboration and gave the WCHRU a plat-
form for subsequent growth and expansion.
More than many in public health at that time, Drs.
Kodkany and Goudar understood the need to describe risk
factors and pregnancy outcomes for specific populations.
[1] Not only did they understand the need, but they also
implemented systems to capture complete pregnancy-
related data in a catchment area in which 10,000–15,000women gave birth each year. Their surveillance system
identified all women likely to get pregnant and therefore
was able to ascertain pregnancy-related risk factors from
preconception and early pregnancy. As an example, for a
trial of low-dose aspirin to reduce risk of preterm birth,
which required nulliparous women to be enrolled in the
first trimester of pregnancy, they were able to recruit more
than 70% of women prior to 10 weeks gestational age [2].
For a number of GN studies, rates of follow-up - always
greater than 99% - data capture and entry within appro-
priate time windows, and the overall quality of data have
been superb [3].
It is therefore not surprising that when funding agencies
have sought sites to carry out important research projects,
they often selected Drs. Kodkany and Goudar and their
team. These funders include the National Institute of Child
Health and Human Development (NICHD) and The
Fogarty International Centre of the United States, The
World Health Organization (WHO), The Bill and Melinda
Gates Foundation (BMGF), The Thrasher Foundation, The
UK Medical Research Council and the Department of Bio-
technology, Government of India, among others.
As the opportunities have grown, the WCHRU team
has expanded their catchment areas and included a
number of neighboring universities. Most impressively,
the JNMC WCHRU has forged a strong public-private
partnership with the public-sector health care system
covering more than 500 villages of the Belagavi and
Bagalkot districts in India. Further, the research unit has
established research collaborations with six leading
medical colleges in Vijayapura, Bagalkot, Davanagere,
Nagpur, Cuttack and Varanasi and has served as the co-
ordinating center for a wide variety of research and
training endeavors. They are thus teaching an ever-
expanding group of Indian research scientists best re-
search practices. As an example, when the WCHRU
team at KLE was approached about a potential BMGF
grant to determine cause of death in stillbirths and pre-
term neonates, they reached out to the JJM Medical Col-
lege in Davanagere, a city located 250 km to the south of
Belagavi with good clinical care but limited research ex-
perience. The KLE WCHRU team made many visits to
Davanagere, worked out all the research protocols and
procedures, and have assumed oversight of the project.
There is little doubt that with their experience in this
project, JJM Medical College in Davanagere will soon be
able to participate in large international research pro-
jects on their own, with little help or oversight needed.
Within India, this is a great example of both north/south
and south/south collaboration.
The NICHD global network
Because much of the work and many of the WCHRU
collaborators are associated with the NICHD Global
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network [4]. Originally funded in the year 2001 by Eunice
Kennedy Shriver NICHD and the BMGF and continually
supported since by NICHD with a number of individual
studies supported by BMGF, the GN brings together seven
partnerships between investigators from US institutions
and investigators from low and middle-income country
institutions. KLE’s WCHRU partnership is currently with
Thomas Jefferson University in Philadelphia, USA.
Since 2008, each site in the GN has maintained a regis-
try of all pregnancies and their outcomes in a defined geo-
graphic area [4]. The registry now has data on over
600,000 pregnancies. Papers in this supplement dealing
with stillbirth and early pregnancy loss are derived from
registry data. As important as the registry, each GN site
has also defined 10 to 20 population-based clusters with
about 500 deliveries per year and have randomized these
clusters for important population-based studies. KLE’s
WCHRU has contributed more subjects to the registry
and these cluster-randomized studies than any other GN
site. Examples of these include studies on the use of ante-
natal corticosteroids, [5] nutritional supplementation, [6]
low-dose aspirin [2] and newborn resuscitation [7].
In addition, outside the GN funded research, the
JNMC WCHRU is testing interventions aimed at redu-
cing maternal and newborn mortality and morbidity
from postpartum haemorrhage, preterm birth, hyperten-
sive disorders of pregnancy and nutritional deficiencies.
The outcomes of the research carried out by the unit
have influenced public health policy, both nationally and
globally, and have received international acclaim.
Papers in this supplement
The papers in this supplement cover many areas - all re-
lated to the common theme of improving maternal and
child health. One of the sub-themes deals with
pregnancy-related mortality. The paper by Goldenberg
et al. provides an overview of maternal, fetal and neo-
natal mortality in low-income countries, considers their
causes, and explores the interventions that have been
used in high-income countries to lower these mortality
rates [8]. An interesting paper by Dhaded et al., using
data from the GN collected by the KLE group, explores
pregnancies terminating prior to 20 weeks gestation
from both spontaneous miscarriage and medical termin-
ation and estimates that of 1000 pregnancies ongoing at
6 weeks, only 60% will be ongoing at 20 weeks and ex-
plores the risk factors for spontaneous miscarriages and
the characteristics of women who have medical termina-
tions [9]. Saleem et al., members of the GN from
Pakistan and long-time collaborators within the GN,
evaluate stillbirth rates and risk factors in seven global
network sites including two in India [10]. Most import-
antly, they conclude that even though stillbirth rates arefalling in all sites, with the current trend, the 2030
WHO goals for a stillbirth rate of 12/1000 births in
every country will not be met in any GN site. Closely re-
lated to maternal mortality is serious maternal morbid-
ity. Geller et al. summarize the research related to
serious maternal morbidity throughout the world [11].
Dr. McClure, a US collaborator and the principal in-
vestigator for the GN Data Coordinating Center, in her
paper, describes the study on cause of death in stillborn
infants and preterm neonates that will take place in
Davanagere and a site in Pakistan [12]. While there are
many interesting issues raised in the paper, perhaps most
important for research in India, are the introduction of
minimally invasive tissue sampling as a way to achieve
the goals of an autopsy without an incision and the use
of multiplex polymerase chain reactions (PCR) to deter-
mine the presence of a wide variety of potentially lethal
organisms in the newborns and fetuses who die. Expand-
ing the capability of its research sites has been a goal of
the GN and KLE University.
There are three additional themes for the papers in the
supplement, all stemming from research conducted by
KLE’s WCHRU. For example, the major killer of pregnant
women worldwide and in India is post-partum hemorrhage.
The KLE WCHRU group, working with their US collabor-
ator, Dr. Derman, has been a leader in research in this area
for the past 20 years. They performed some of the most im-
portant work on measuring post-partum blood loss [13] and
on the use of misoprostol, an agent that can be given orally
or per vagina that causes the uterus to contract and controls
post-partum bleeding [14]. In this issue, Theunissen et al.
describe two ongoing clinical trials using a heat stable
uterotonic, Carbetocin [15]. If successful, the use of this
medication will provide the most effective agent to prevent
post-partum hemorrhage to be used in areas where refriger-
ation is not available. Also related to post-partum
hemorrhage, Piaggio et al. explore methodologies to perform
blood loss studies using more attainable sample sizes [16].
Another major killer of women, fetuses and newborns is
preeclampsia/eclampsia. The KLE WCHRU was one of
four organizations chosen by BMGF to participate in the
Community-Level Interventions for Pre-eclampsia (CLIP)
trial to evaluate a number of strategies related to better
diagnosing and treating this disease [17]. In this issue,
Katageri et al. explored the use of magnesium sulfate in
the Belagavi area to reduce eclamptic seizures [18] and
found that the use of this intervention was very low. Vous-
den et al. explore issues related to determining hyperten-
sion and shock, predominantly by accurately measuring
blood pressure and emphasize the importance of accurate
measurement [19]. Charanthimath et al. explore the accept-
ability of using lower level health workers to perform tasks
such as blood pressure monitoring and administration of
various medications prior to transfer in pregnant women
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the diagnosis of hypertension can be made during prenatal
care with transfer to a facility capable of providing appro-
priate care, it is unlikely that the appropriate treatments
can be applied to reduce the stillbirths, asphyxia-related
neonatal mortality and the maternal mortality associated
with pregnancy-related hypertension. In general, they found
that most people in the community, but not all physicians,
approved of using lower level health workers to screen
pregnant women for hypertension and provide initial treat-
ment. The need for appropriate training was emphasized,
especially by the physicians.
Still another line of KLE WCHRU research has focused
on nutritional issues during pregnancy including anemia,
iron deficiency and the effect of iron on development. The
KLE group was one of four GN sites to participate in a
major BMGF funded trial to assess the impact of precon-
ceptional nutrition on neonatal growth, Women First,
whose results will be published later this year [6]. Drs.
Hambidge and Krebs review several of the issues addressed
in the Women First and other trials related to nutritional
supplementation to improve infant development [21]. But
this represents just the latest effort to understand the rela-
tionship of maternal nutritional status and pregnancy out-
come. In this issue, Masthiholi et al. present results from a
study in Karnataka, India on the nutritional status of Indian
pregnant women [22]. They focus on the very high preva-
lence of anemia, low maternal weight and food insecurity
among the pregnant population. Finally, there are several
papers related to iron status. Dr. Auerbach explains why
iron deficiency and its related anemia is so common in
countries like India, as well as why oral iron treatment is
often ineffective. He makes the case for the more frequent
use of intravenous iron treatment [23]. Taking a different
direction, Moos et al. describe a model of iron deficiency
during pregnancy in rats and the impact of low iron on rat
fetal brain development [24]. They describe how maternal
parenteral treatment at different times in pregnancy returns
fetal brain iron stores to normal levels.
Finally, Dr. Derman considers issues related to dissemin-
ation and implementation of the results of research trials
[25]. It should be clear that unless the results of research
are used to improve clinical care and help to influence pol-
icies related to health care, important opportunities to
improve the health of women and children are lost.
Conclusions
In this paper, we present a very brief summary of research
performed by the KLE WCHRU group and its collabora-
tors. This effort is a great example of dedicated investiga-
tors building a research program focusing on important
outcomes starting with an understanding of the need
for population-based research and gradually expanding
that research from observational studies to randomizedcontrolled trials, to studies of the mechanism of disease
using sophisticated technologies. As they have been
building their research program, they have expanded in
a number of important ways. These include adding col-
laborators from many different disciplines within KLE,
adding collaborators from outside India including
members of the GN sites, funding partners and re-
search collaborators such as those from The University
of British Columbia and the CLIP trial [17]. Finally and
perhaps most impressively, the KLE WCHRU group
has used their resources to expand their research into
other geographic areas and to build capacity at a num-
ber of nearby universities. Instead of viewing these in-
stitutions as potential competitors, they view them as
collaborators, which has increased their overall prod-
uctivity. The growth and development of the KLE
JNMC WCHRU over the last 20 years into a world-
class research institution and their impressive accom-
plishments, serves as a great example and learning
experience for us all.
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